Dow Up 1.33% Nasdaq Up 1.33%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
13.72 Down 1.34(8.90%) 4:00PM EDT
|After Hours : 13.72 0.00 (0.00%) 5:29PM EDT
Prev Close:15.06
Open:14.64
Bid:12.00 x 100
Ask:13.88 x 100
1y Target Est:17.50
Beta:1.26498
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:13.10 - 14.88
52wk Range:11.57 - 116.75
Volume:3,729,397
Avg Vol (3m):1,549,510
Market Cap:526.65M
P/E (ttm):N/A
EPS (ttm):-10.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLVSDown 8.90%526.65M
IMMUUp 3.11%219.95M
THLDUp 9.01%45.44M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-8.00
Quarterly EPS Est (Jun-16) :-2.13
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback